Literature DB >> 32623937

Emerging Role of Syndecans in Extracellular Matrix Remodeling in Cancer.

Bohee Jang1, Ayoung Kim1, Jisun Hwang1, Hyun-Kuk Song1, Yunjeon Kim1, Eok-Soo Oh1.   

Abstract

The extracellular matrix (ECM) offers a structural basis for regulating cell functions while also acting as a collection point for bioactive molecules and connective tissue cells. To perform pathological functions under a pathological condition, the involved cells need to regulate the ECM to support their altered functions. This is particularly common in the development of cancer. The ECM has been recognized as a key driver of cancer development and progression, and ECM remodeling occurs at all stages of cancer progression. Thus, cancer cells need to change the ECM to support relevant cell surface adhesion receptor-mediated cell functions. In this context, it is interesting to examine how cancer cells regulate ECM remodeling, which is critical to tumor malignancy and metastatic progression. Here, we review how the cell surface adhesion receptor, syndecan, regulates ECM remodeling as cancer progresses, and explore how this can help us better understand ECM remodeling under these pathological conditions.

Entities:  

Keywords:  ECM remodeling; cancer; extracellular matrix; glycosaminoglycan; matrix metalloprotease; syndecan

Mesh:

Substances:

Year:  2020        PMID: 32623937      PMCID: PMC7711240          DOI: 10.1369/0022155420930112

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  82 in total

Review 1.  Modulation of cell-fibronectin matrix interactions during tissue repair.

Authors:  Kim S Midwood; Yong Mao; Henry C Hsia; Leyla V Valenick; Jean E Schwarzbauer
Journal:  J Investig Dermatol Symp Proc       Date:  2006-09

2.  Syndecan-2 is expressed in the microvasculature of gliomas and regulates angiogenic processes in microvascular endothelial cells.

Authors:  Constance Y Fears; Candece L Gladson; Anne Woods
Journal:  J Biol Chem       Date:  2006-03-30       Impact factor: 5.157

3.  Heparan sulfate chains of syndecan-1 regulate ectodomain shedding.

Authors:  Vishnu C Ramani; Pamela S Pruett; Camilla A Thompson; Lawrence D DeLucas; Ralph D Sanderson
Journal:  J Biol Chem       Date:  2012-02-01       Impact factor: 5.157

4.  Elevated Syndecan-1 levels in the sera of patients with breast cancer correlate with tumor size.

Authors:  Zahra Malek-Hosseini; Sina Jelodar; Abdolrasoul Talei; Abbas Ghaderi; Mehrnoosh Doroudchi
Journal:  Breast Cancer       Date:  2017-04-05       Impact factor: 4.239

5.  Syndecan-4 ectodomain evokes mobilization of podocyte TRPC6 channels and their associated pathways: An essential role for integrin signaling.

Authors:  Eun Young Kim; Hila Roshanravan; Stuart E Dryer
Journal:  Biochim Biophys Acta       Date:  2015-07-17

6.  Cadherin-11 is a novel regulator of extracellular matrix synthesis and tissue mechanics.

Authors:  Sindhu Row; Yayu Liu; Stella Alimperti; Sandeep K Agarwal; Stelios T Andreadis
Journal:  J Cell Sci       Date:  2016-06-16       Impact factor: 5.285

7.  Shed syndecan-2 enhances tumorigenic activities of colon cancer cells.

Authors:  Sojoong Choi; Youngsil Choi; Eunsung Jun; In-San Kim; Seong-Eun Kim; Sung-Ae Jung; Eok-Soo Oh
Journal:  Oncotarget       Date:  2015-02-28

8.  Syndecan-4-dependent Rac1 regulation determines directional migration in response to the extracellular matrix.

Authors:  Mark D Bass; Kirsty A Roach; Mark R Morgan; Zohreh Mostafavi-Pour; Tobias Schoen; Takashi Muramatsu; Ulrike Mayer; Christoph Ballestrem; Joachim P Spatz; Martin J Humphries
Journal:  J Cell Biol       Date:  2007-05-07       Impact factor: 10.539

Review 9.  Syndecans as modulators and potential pharmacological targets in cancer progression.

Authors:  Despoina Barbouri; Nikolaos Afratis; Chrisostomi Gialeli; Demitrios H Vynios; Achilleas D Theocharis; Nikos K Karamanos
Journal:  Front Oncol       Date:  2014-02-03       Impact factor: 6.244

Review 10.  Targeting ECM Disrupts Cancer Progression.

Authors:  Freja A Venning; Lena Wullkopf; Janine T Erler
Journal:  Front Oncol       Date:  2015-10-20       Impact factor: 6.244

View more
  1 in total

1.  Altered Distribution and Expression of Syndecan-1 and -4 as an Additional Hallmark in Psoriasis.

Authors:  Eleni Koliakou; Manthou Maria Eleni; Ioanna Koumentakou; Nikolaos Bikiaris; Polyanthi Konstantinidou; Patricia Rousselle; Doxakis Anestakis; Elisabeth Lazaridou; Evangelia Kalloniati; Miliaras Dimosthenis; Anna Michopoulou
Journal:  Int J Mol Sci       Date:  2022-06-10       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.